FibroBiologics

FBLG • NASDAQ • Stock Fundamentals

FibroBiologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter O'Heeron, with a market cap of $5.0M.

Market Cap$5.0M

Employees8.0

CEOPeter O'Heeron

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026

Next EarningsJul 30, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about FibroBiologics

FibroBiologics (FBLG) has a market capitalization of $5.0M and trades on NASDAQ.

FibroBiologics has approximately 8 employees.